Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Bognel

Showing results (91-100 of 95) with videos related to

Pageof 10
Sort By:
You have reached the last page of results.This site can display upto 95 results.
Gastroenterologie Clinique Et Biologique|January 1, 1990
[Primitive digestive localizations of malignant non-Hodgkin's lymphoma. Prognostic factors of locally advanced disease: stage II. Report of 67 cases]P Rougier, M Azab, M Henry-Amar, et al.
Cancer Research|April 1, 1993
Pharmacokinetic and pharmacodynamic advantages of pirarubicin over adriamycin after intraarterial hepatic administration in the rabbit VX2 tumor modelJ N Munck, M Riggi, P Rougier, et al.
British Journal of Cancer|July 2, 1998
Electrochemotherapy on liver tumours in rabbitsL H Ramirez, S Orlowski, D An, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1994
Phase I and pharmacological study of intra-arterial hepatic administration of pirarubicin in patients with advanced hepatic metastasesJ N Munck, P Rougier, G G Chabot, et al.
Cancer|September 15, 1989
Prognostic factors in primary gastrointestinal non-Hodgkin's lymphoma. A multivariate analysis, report of 106 cases, and review of the literatureM B Azab, M Henry-Amar, P Rougier, et al.
Pageof 10

Showing results (91-100 of 95) with videos related to

Sort By:
Pageof 10
You have reached the last page of results.This site can display upto 95 results.
Gastroenterologie Clinique Et Biologique|January 1, 1990
[Primitive digestive localizations of malignant non-Hodgkin's lymphoma. Prognostic factors of locally advanced disease: stage II. Report of 67 cases]P Rougier, M Azab, M Henry-Amar, et al.
Cancer Research|April 1, 1993
Pharmacokinetic and pharmacodynamic advantages of pirarubicin over adriamycin after intraarterial hepatic administration in the rabbit VX2 tumor modelJ N Munck, M Riggi, P Rougier, et al.
British Journal of Cancer|July 2, 1998
Electrochemotherapy on liver tumours in rabbitsL H Ramirez, S Orlowski, D An, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1994
Phase I and pharmacological study of intra-arterial hepatic administration of pirarubicin in patients with advanced hepatic metastasesJ N Munck, P Rougier, G G Chabot, et al.
Cancer|September 15, 1989
Prognostic factors in primary gastrointestinal non-Hodgkin's lymphoma. A multivariate analysis, report of 106 cases, and review of the literatureM B Azab, M Henry-Amar, P Rougier, et al.
Pageof 10